The ultrasound division of Toshiba America Medical Systems in Tustin, CA, has received 510(k) clearance for two harmonic imaging options for its PowerVision 7000 scanner. The clearance includes both tissue harmonic and contrast harmonic options,
The ultrasound division of Toshiba America Medical Systems in Tustin, CA, has received 510(k) clearance for two harmonic imaging options for its PowerVision 7000 scanner. The clearance includes both tissue harmonic and contrast harmonic options, according to Ross Heaton, director of ultrasound marketing.
Like tissue harmonic packages from other companies, Toshiba's offering enables users to reduce noise in ultrasound scans by imaging only returning echoes at frequencies that are harmonic multiples of the original ultrasound transmission. The company's contrast harmonic package, however, is substantially different from contrast packages from other vendors.
Called Flash Echo Imaging, the option delivers sound waves in pulses that reduce the acoustic energy of the ultrasound beam below the intensity at which contrast microbubbles burst. The technique preserves contrast agent microbubbles, allowing new bubbles to enter the scan plane before the next sequence, thus improving image quality.
Toshiba began shipping the options on PowerVision 7000 this month. The tissue harmonic and Flash Echo Imaging options carry a list price of $10,000 each, or are available as a package for $15,000. Toshiba also plans to submit the options for clearance on the company's PowerVision 6000 scanner, which was introduced in May (SCAN 5/27/98).
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.